← Back to search
THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Doing business as HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC
BETHESDA, MD, 20817
UnclaimedClaim this profile (free)
Prime contracting experience
42 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Veterans Affairs Department of Veterans Affairs | WAR RELATED ILLNESS AND INJURY STUDY ON VETERANS AFTER DEPLOYMENT | — | $3,960,106 | Sep 8, 2026 | Sep 29, 2023 – Sep 28, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | TRAUMATIC BRAIN INJURIES (TBI) AND ANOMALOUS HEALTH INCIDENCES (AHI) | — | $4,639,796 | Aug 28, 2026 | Sep 27, 2022 – Sep 30, 2027 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | DEVELOPMENT OF CLINICAL PRACTICE GUIDELINES TO SUPPORT CARE OF MILITARY- RELEVANT INFECTIOUS DISEASES UNIFORMED SERVICES UNIVERSITY FOR THE HEALTH SCIENCES (USU), INFECTIOUS DISEASECLINICAL RESEARCH PROGRAM (IDCRP)//S/A CLARIFIED PLACE OF PERFORMANCE | HT001122D0022USAspending | $11,118,121 | Jul 13, 2026 | Sep 30, 2024 – Dec 29, 2026 |
| Prime | Department of Defense Defense Health Agency | MILITARY READINESS RESEARCH SUPPORT SERVICES | — | $22,601,400 | Jun 30, 2026 | Aug 28, 2020 – Jun 30, 2027 |
| Prime | Department of Defense Defense Health Agency | DIGITAL TWIN RESEARCH SUPPORT SERVICES | HT001122D0022USAspending | $4,527,376 | Jun 25, 2026 | Jun 3, 2024 – Jun 30, 2027 |
| Prime | Department of Defense Defense Health Agency | NON PERSONAL SERVICES FOR SURVEILLANCE OF EMERGING INFECTIOUS DISEASES IN KENYA, UGANDA, TANZANIA AND SUB SAHARA AFRICA FOR THE WALTER REED ARMY INSTITUTE OF RESEARCH - MEDICAL RESEARCH DETACHMENT - AFRICA. | — | $38,586,698 | Jun 25, 2026 | Aug 29, 2021 – Sep 28, 2026 |
| Prime | Department of Defense Defense Health Agency | EXOSKELETON RESEARCH SUPPORT SERVICES | — | $4,645,596 | Jun 9, 2026 | May 8, 2024 – Jun 30, 2027 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | WAR RELATED STUDIES | — | $1,263,838 | Jun 5, 2026 | Apr 30, 2025 – Apr 29, 2026 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | MENINGOCOCCAL IMMUNIZATION AGAINST GONOCOCCAL INFECTION (MAGI) TRIAL/ RV564 | — | $785,171 | May 19, 2026 | Sep 30, 2025 – Mar 29, 2027 |
| Prime | Department of Defense Defense Health Agency | NON PERSONAL SUPPORT SERVICES FOR DIAGNOSTIC COUNTERMEASURES BRANCH AT THE WALTER REED ARMY INSTITUTE OF RESEARCH, SILVER SPRING, MD. | — | $33,358,154 | May 11, 2026 | Sep 1, 2023 – Aug 31, 2026 |
| Prime | Department of Defense Defense Health Agency | EVIDENCE BASED INJURY CRITERIA RESEARCH STUDY | — | $1,912,050 | May 4, 2026 | Sep 1, 2023 – Nov 29, 2026 |
| Prime | Department of Defense Defense Health Agency | CASUALTY CARE ASSESSMENT: RUSSO-UKR WAR | — | $12,386,614 | Apr 13, 2026 | Feb 15, 2023 – Sep 29, 2025 |
| Prime | Department of Defense Department of the Air Force | HISTORY BOOK WRITER/ TECHNICAL WRITER AND ARCHIVAL SERVICES | 47QRAA21D0016USAspending | $265,204 | Mar 23, 2026 | Mar 23, 2026 – Aug 31, 2026 |
| Prime | Department of Defense Defense Health Agency | TOXICOLOGY RESEARCH SUPPORT SERVICES | HT001122D0022USAspending | $2,227,250 | Mar 18, 2026 | Jul 1, 2024 – Jun 30, 2027 |
| Prime | Department of Defense Defense Health Agency | HDRL /LDL REF. LAB SUPPORT | — | $37,784,099 | Mar 5, 2026 | Jun 8, 2018 – Aug 31, 2023 |
| Prime | Department of Defense Defense Health Agency | RESEARCH & DEVELOPMENT SERVICES | — | $709,809 | Feb 23, 2026 | Jun 3, 2024 – Sep 2, 2026 |
| Prime | Department of Defense Department of the Air Force | PKF - MOSS - RAYFORD CAGE - HOLISTIC HEALTH APPROACH PREVENTION AND SKILL-BUILDING CURRICULUM (TRAINING AIDS) | — | $258,865 | Nov 19, 2025 | Sep 27, 2024 – Jun 30, 2026 |
| Prime | Department of Defense Defense Health Agency | UKRAINE. PROVIDE CONTINUED RESEARCH AND DEVELOPMENT TO THE CASUALTY CARE ASSESSMENT OF RUSSO-UKRAINE WAR. | — | $3,972,974 | Sep 18, 2025 | Sep 30, 2025 – Sep 29, 2026 |
| Prime | Department of Defense Department of the Air Force | PROFESSIONAL ARCHIVAL SERVICES | 47QRAA21D0016USAspending | $265,126 | Aug 27, 2025 | Sep 21, 2023 – Feb 28, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PTSD EVIDENCED BASED TREATMENT, PTSD ASSESSMENT, AND MILITARY CULTURE TRAINING | — | $382,651 | Aug 14, 2025 | Sep 1, 2021 – Aug 31, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | HENRY M. JACKSON FOUNDATION FOR THE ADVANCE OF MILITARY MEDICINE INC. - MILITARY HEALTH SYS | — | $888,001 | Jul 30, 2025 | Aug 10, 2021 – Feb 8, 2026 |
| Prime | Department of Defense Department of the Air Force | HISTORICAL DATA SCIENTIFIC SERVICES | 47QRAA21D0016USAspending | $309,046 | Jul 10, 2025 | Sep 30, 2024 – Feb 28, 2026 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | SCREENING OF CUTANEOUS RADIATION INJURY COUNTERMEASURES IN THE GOTTINGEN MINIPIG MODEL | HT001122D0022USAspending | $858,105 | Jul 3, 2025 | Jul 23, 2024 – Jul 22, 2027 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | DRUG SCREEN FOR RADIATION COMBINED INJURY IN MICE | HT001122D0022USAspending | $767,795 | Jul 3, 2025 | Jul 23, 2024 – Jul 22, 2027 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | EVALUATION OF RADIATION MEDICAL COUNTERMEASURE MITIGATION IN MULTI-ORGAN PARTIAL BODY IRRADIATION MOUSE MODEL | HT001122D0022USAspending | $876,213 | Jul 3, 2025 | Jul 23, 2024 – Jul 22, 2027 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | PROGRAMMATIC SUPPORT | HU000122D0005USAspending | $703,904 | Jul 1, 2025 | Sep 26, 2022 – Sep 25, 2025 |
| Prime | Department of Defense Defense Health Agency | RESEARCH AND DEVELOPMENT | — | $6,209,903 | Jun 11, 2025 | Sep 30, 2022 – Sep 29, 2024 |
| Prime | Department of Defense Defense Health Agency | RESEARCH SO190033. EO14042 - RESEARCH SO190033 - "TESTING AN ADVANCED ULTRALIGHT INFRARED INTRACRANIAL HEMORRHAGE DETECTION DEVICE IN A SHEEP MODEL OF LIFE-THREATENING SUBDURAL HEMATOMA" | — | $1,179,689 | May 9, 2025 | Dec 15, 2021 – Dec 14, 2025 |
| Prime | Department of Defense Defense Health Agency | PROPOSAL LOG NO. BA200139 | — | $1,048,431 | May 2, 2025 | Sep 15, 2021 – Sep 30, 2024 |
| Prime | Department of Defense Defense Health Agency | INFECTIOUS DISEASE CLINICAL PHYSICIAN | — | $391,525 | Mar 26, 2025 | Aug 31, 2021 – Feb 28, 2023 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | DEVELOP MEDICAL COUNTERMEASURES FOR MITIGATION EFFICACY AGAINST RADIATION-INDUCED LETHALITY IN THE H-ARS MOUSE MODEL | HT001122D0022USAspending | $330,343 | Oct 9, 2024 | Jul 23, 2024 – Jul 22, 2025 |
| Prime | Department of Defense Uniformed Services University of the Health Sciences | MAGI TRIAL RESEARCH SUPPORT | — | $6,068,588 | Sep 12, 2024 | Sep 30, 2022 – Sep 29, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | WAR RELATED STUDY/RESEARCH SUPPORT SERVICES | — | $666,055 | Mar 29, 2024 | Apr 1, 2024 – Mar 31, 2025 |
| Prime | Department of Homeland Security U.S. Coast Guard | RESILIENCE COORDINATOR TRAIN THE TRAINER CURRICULUM DEVELOPMENT AND TRAINING | 47QRAA21D0016USAspending | $534,190 | Mar 8, 2024 | Sep 25, 2023 – Sep 24, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RESEARCH FOR WAR RELATED ILLNESSES | — | $489,205 | Feb 7, 2024 | Sep 30, 2023 – Feb 29, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | ADMINISTRATIVE SERVICE - IGF::OT::IGF | — | $260,920 | Sep 26, 2023 | Sep 30, 2017 – Sep 29, 2019 |
| Prime | Department of Defense Department of the Army | IGF::OT::IGF PROPOSAL LOG # BA160527 | — | $648,530 | Aug 15, 2023 | Sep 29, 2017 – Jun 6, 2022 |
| Prime | Department of Defense Department of the Army | IGF::CT::IGF NON PERSONAL SUPPORT SERVICES GLOBAL EMERGING INFECTIOUS DISEASES | — | $33,286,545 | Jun 12, 2023 | Sep 27, 2016 – Aug 28, 2021 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | IGF::OT::IGF RESEARCH SERVICES | — | $2,257,032 | Dec 15, 2022 | Sep 30, 2018 – Sep 29, 2023 |
| Prime | Department of Defense Department of the Army | IGF::OT::IGF R&D CONTRACT FOR CDMRP, LOG NO. JW140111 | — | $2,383,695 | Nov 15, 2022 | Jul 1, 2015 – Dec 31, 2022 |
| Prime | Department of Defense Department of the Army | IGF::OT::IGF FUNDING FOR CLIN 0001 | — | $5,864,593 | Dec 14, 2021 | Sep 16, 2015 – Jul 31, 2021 |
| Prime | Department of Defense Department of the Navy | IGF::OT::IGF RESEARCH SUPPORT SERVICES IN SUPPORT OF NAMRU-DAYTON. | — | $12,590,247 | Nov 4, 2021 | Mar 8, 2016 – Jul 7, 2019 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
21 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Defense | "SPECIFIC AIMS: CARRY OUT A PHASE 2B CLINICAL TRIAL INCLUDING A 4-WEEK, PLACEBO-CONTROLLED, DOUBLE-MASKED DOSE FINDING AND SAFETY-TOLERABILITY STUDY OF APPROXIMATELY 160 PARTICIPANTS WITH CHRONIC TBI (79 AT WRNMMC) MORE THAN 6 MONTHS PRIOR TO ENROLLMENT AND WHO REMAIN SYMPTOMATIC AND DISABLED WITH THE FOLLOWING STUDY AIMS:
AIM 1 (PRIMARY AIM- PHARMACODYNAMIC): TO DETERMINE THE OPTIMAL PDE5 INHIBITOR DOSE TO IMPROVE MICROVASCULAR FUNCTION (CVR MEASURES) AFTER A SINGLE PDE5 INHIBITOR DOSE.
AIM 2 (PRIMARY AIM- SAFETY AND TOLERABILITY): TO ASSESS THE SAFETY AND TOLERABILITY OF A RANGE OF PDE5 INHIBITOR DOSES IN CHRONIC MODERATE-SEVERE TBI SUBJECTS.
AIM 3 (SECONDARY/EXPLORATORY AIM): TO MEASURE THE EFFECT OF CHRONIC (4-WEEK) PDE-5 INHIBITOR ADMINISTRATION AT 3 DIFFERENT DOSES ON TBI SYMPTOM SELF-REPORT AND FUNCTIONAL OUTCOME MEASURES." 585970 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541715 Parent award performance state: PA Parent award description: BROAD AGENCY ANNOUNCEMENT (BAA) AWARD RESULTING FROM PROPOSAL TP210611 View parent award on USAspending | — | $147,440 | Jul 10, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | TEST EFFICACY OF ANTI-CERAMIDE ANTIBODY PLUS NEULASTA IN A PARTIAL BODY IRRADIATION MOUSE MODEL 002 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: NY Parent award description: DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE View parent award on USAspending | — | $203,496 | Jun 27, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | HARMONIZE PARTIAL BODY IRRADIATION MOUSE MODELS. 002 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: NY Parent award description: DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE View parent award on USAspending | — | $124,956 | Mar 1, 2025 | — – — |
| Subcontractor | Department of Defense | RESEARCH AND DEVELOPMENT ACTIVITIES. NSRI-HJF-F0086-001 Parent award context Parent award agency: Department of Defense · Department of the Air Force Parent award NAICS: 541715 Parent award performance state: NE Parent award description: MEDICAL COUNTERMEASURE DRUG DISCOVERY & DEVELOPMENT INCREMENT 3 View parent award on USAspending | FA460020D0003USAspending | $150,000 | Feb 25, 2025 | — – — |
| Subcontractor | Department of Defense | RESEARCH AND DEVELOPMENT ACTIVITIES NSRI-HJF-0086-001 Parent award context Parent award agency: Department of Defense · Department of the Air Force Parent award NAICS: 541715 Parent award performance state: NE Parent award description: MEDICAL COUNTERMEASURE DRUG DISCOVERY & DEVELOPMENT INCREMENT 3 View parent award on USAspending | FA460020D0003USAspending | $247,000 | Jan 22, 2025 | — – — |
| Subcontractor | Department of Defense | PROCURED GOODS AND/OR SERVICES BETWEEN 29-SEP-24 AND 30-JUN-25 IN SUPPORT OF CONTRACT SOW. P010331364-0 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541714 Parent award performance state: VA Parent award description: DIAGNOSTICS & SURVEILLANCE RESEARCH View parent award on USAspending | HT001122D0028USAspending | $220,598 | Jan 8, 2025 | — – — |
| Subcontractor | Department of Defense | SERVICES PO-0010075 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541712 Parent award performance state: MD Parent award description: OUMD/NMRC RESEARCH SUPPORT SERVICES View parent award on USAspending | GS00Q14OADU425USAspending | $2,806,460 | Dec 3, 2024 | — – — |
| Subcontractor | Department of Defense | SERVICES PO-0010075 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541712 Parent award performance state: MD Parent award description: OUMD/NMRC RESEARCH SUPPORT SERVICES View parent award on USAspending | GS00Q14OADU425USAspending | $2,517,660 | Sep 10, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOP AND CHARACTERIZE MALE AND FEMALE PARTIAL BODY IRRADIATION (PBI) MOUSE MODELS. USE THE NEWLY DEVELOPED MODELS TO EVALUATE EFFICACY OF A LEAD ANTI-CERAMIDE COMPOUND. 002 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: NY Parent award description: DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE View parent award on USAspending | — | $407,771 | Jun 13, 2024 | — – — |
| Subcontractor | Department of Defense | RESEARCH AND DEVELOPMENT IN TREATMENT OF TBIS 0000891851 Parent award context Parent award agency: Department of Defense · Defense Advanced Research Projects Agency Parent award NAICS: 541714 Parent award performance state: OH Parent award description: CORNERSTONE PROGRAM View parent award on USAspending | — | $975,247 | May 7, 2024 | — – — |
| Subcontractor | Department of Defense | "SPECIFIC AIMS: CARRY OUT A PHASE 2B CLINICAL TRIAL INCLUDING A 4-WEEK, PLACEBO-CONTROLLED, DOUBLE-MASKED DOSE FINDING AND SAFETY-TOLERABILITY STUDY OF APPROXIMATELY 160 PARTICIPANTS WITH CHRONIC TBI (79 AT WRNMMC) MORE THAN 6 MONTHS PRIOR TO ENROLLMENT AND WHO REMAIN SYMPTOMATIC AND DISABLED WITH THE FOLLOWING STUDY AIMS:
AIM 1 (PRIMARY AIM- PHARMACODYNAMIC): TO DETERMINE THE OPTIMAL PDE5 INHIBITOR DOSE TO IMPROVE MICROVASCULAR FUNCTION (CVR MEASURES) AFTER A SINGLE PDE5 INHIBITOR DOSE.
AIM 2 (PRIMARY AIM- SAFETY AND TOLERABILITY): TO ASSESS THE SAFETY AND TOLERABILITY OF A RANGE OF PDE5 INHIBITOR DOSES IN CHRONIC MODERATE-SEVERE TBI SUBJECTS.
AIM 3 (SECONDARY/EXPLORATORY AIM): TO MEASURE THE EFFECT OF CHRONIC (4-WEEK) PDE-5 INHIBITOR ADMINISTRATION AT 3 DIFFERENT DOSES ON TBI SYMPTOM SELF-REPORT AND FUNCTIONAL OUTCOME MEASURES." 585970 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541715 Parent award performance state: PA Parent award description: BROAD AGENCY ANNOUNCEMENT (BAA) AWARD RESULTING FROM PROPOSAL TP210611 View parent award on USAspending | — | $146,858 | Apr 4, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | GENERATION OF RECOMBINANT ADHESIN-PILLIN ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) ANTIGENS
HJF WILL PRODUCE, CHARACTERIZE AND PROVIDE TULANE WITH UP TO 10 MG OF CFAEB AND CSSBA PROTEINS. ANTIGENS WILL BE USED FOR IMMUNOGENICITY STUDIES AND IMMUNOASSAYS.
GENERATION OF CAMPYLOBACTER JEJUNI CONJUGATE AND CAPSULE POLYSACCHARIDE ANTIGENS HJF WILL PRODUCE, CHARACTERIZE AND PROVIDE TULANE WITH UP TO 10 MG OF AN HS23/36-CRM197 CONJUGATE ANTIGEN FOR IMMUNOGENICITY EVALUATIONS. HJF WILL PRODUCE, CHARACTERIZE AND PROVIDE TULANE WITH UP TO 10 MG OF AN HS23/36 CAPSULE POLYSACCHARIDE ANTIGEN TO BE UTILIZED IN IMMUNOASSAYS.
SUPPORT OF CAMPYLOBACTER JEJUNI SMALL ANIMAL MODEL DEVELOPMENT AND APPLICATION HJF WILL PROVIDE TULANE WITH THE PUBLICLY AVAILABLE C. JEJUNI 81-176 BACTERIAL STRAIN IN ORDER TO PERFORM A C. JEJUNI SMALL ANIMAL MODEL AT TULANE UNIVERSITY. IN ADDITION TO TRANSFERRING THE BACTERIAL STRAIN, HJF PI AND STAFF MEMBER WILL TRAVEL TO TULANE UNIVERSITY AND PROVIDE HANDS-ON
ADVICE AND TECHNICAL TRAINING TO THE TULANE STAFF MEMBERS TO PROPERLY CONDUCT THE STUDIES.
HJF WILL PROVIDE CONTINUED SCIENTIFIC SUPPORT FOR IMMUNOGENICITY AND EFFICACY STUDIES IN ANIMAL
MODELS. TUL-HSC-561745-23/24 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: LA Parent award description: DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA) View parent award on USAspending | — | $256,034 | Dec 8, 2023 | — – — |
| Subcontractor | Department of Defense | RESEARCH AND DEVELOPMENT ACTIVITIES. NSRI-HJF-0086-001 Parent award context Parent award agency: Department of Defense · Department of the Air Force Parent award NAICS: 541715 Parent award performance state: NE Parent award description: MEDICAL COUNTERMEASURE DRUG DISCOVERY & DEVELOPMENT INCREMENT 3 View parent award on USAspending | FA460020D0003USAspending | $252,973 | Sep 1, 2023 | — – — |
| Subcontractor | Department of Defense | FURTHER DEVELOPMENT OF 5-AED (ANDROSTENEDIOL, NEUMUNE) FOR THE PROTECTION OF ACUTE
RADIATION SYNDROME (ARS) 35-5140-2059-401 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541715 Parent award performance state: NE Parent award description: RESEARCH AND DEVELOPMENT CONTRACT, PROPOSAL JW210398 TITLED "FURTHER DEVELOPMENT OF 5-AED (ANDROSTENEDIOL, NEUMUNE) FOR THE PROTECTION FROM ACUTE RADIATION SYNDROME (ARS)," ON BEHALF OF CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS View parent award on USAspending | — | $1,559,433 | Aug 30, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOP AND CHARACTERIZE MALE AND FEMALE PARTIAL BODY IRRADIATION (PBI) MOUSE MODELS. USE THE NEWLY DEVELOPED MODELS TO EVALUATE EFFICACY OF A LEAD ANTI-CERAMIDE COMPOUND. 002 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: NY Parent award description: DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE View parent award on USAspending | — | $409,973 | Jun 29, 2023 | — – — |
| Subcontractor | Department of Defense | RESEARCH AND DEVELOPMENT ACTIVITIES. NSRI-HJF-U910-001 Parent award context Parent award agency: Department of Defense · Department of the Air Force Parent award NAICS: 541715 Parent award performance state: NE Parent award description: LABOR, OFF SITE View parent award on USAspending | FA460018D9001USAspending | $168,988 | Apr 24, 2023 | — – — |
| Subcontractor | Department of Defense | SERVICES GDIT-16592 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541611 Parent award performance state: MD Parent award description: TRAUMATIC BRAIN INJURY CENTER OF EXCELLENCE RESEARCH AND SUPPORT SERVICES View parent award on USAspending | — | $898,530 | Nov 11, 2022 | — – — |
| Subcontractor | Department of Defense | USUHS WILL DEVELOP A DETAILED EXPERIMENTAL PLAN FOR THE ANIMAL MODEL STUDIES THAT WILL BE CARRIED OUT IN THIS PHASE II PROJECT TO EVALUATE THE USE OF THIS DEVICE FOR TREATING AKI AND SIMILAR COMPLICATIONS. GS.1403.025.HJF .22.01 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: DHA 2020.2 SBIR PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2-0650, TITLED: "TECHNOLOGY FOR PORTABLE DIALYSATE GENERATOR" LOG #21000272 View parent award on USAspending | — | $144,347 | Sep 19, 2022 | — – — |
| Subcontractor | Department of Defense | CLINICAL RESEARCH GSS0047 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541990 Parent award performance state: VA Parent award description: DEFENSE HEALTH AGENCY IMMUNIZATION HEALTHCARE DIVISION CLINICAL STUDIES SUPPORT AND HEALTH APPLICATIONS SYSTEMS SUPPORT SERVICES View parent award on USAspending | — | $3,028,776 | Aug 27, 2022 | — – — |
| Subcontractor | Department of Defense | IT HEALTH SERVICES MASI1-19-S-TM-0249 MOD015 Parent award context Parent award agency: Department of Defense · Defense Contract Management Agency Parent award NAICS: 541715 Parent award performance state: VA Parent award description: FORCE HEALTH PROTECTION, ANALYSIS, ASSESSMENT, AND EVALUATION FOR NAVY AND MARINE CORPS PUBLIC HEALTH CENTER View parent award on USAspending | FA807518D0011USAspending | $7,755,915 | Jun 10, 2022 | — – — |
| Subcontractor | Department of Defense | • SPECIFIC AIM 1: OPTIMIZE THE LMM AND CMM SPINE HEALTH SYSTEMS BY COLLECTING,
ANALYZING, AND TRACKING FUNCTIONAL SPINE HEALTH OVER TIME IN VARIOUS MTFS/SITES.
• SPECIFIC AIM 2: VALIDATE THE UTILITY OF THE LMM AND CMM SYSTEMS (REFERRED TO
JOINTLY AS PHENO SYSTEM) AND OTHER BIOPSYCHOSOCIAL METRICS TO INFORM CLINICAL
DECISION-MAKING, OPTIMIZE TREATMENT, AND PREDICT LONG-TERM OUTCOMES OF SERVICE
MEMBERS WITH BACK AND/OR NECK PAIN.
• SPECIFIC AIM 3: SUBMIT AND OBTAIN FDA APPROVAL FOR WIDESPREAD CLINICAL USE OF LMM
AND CMM WITHIN THE MILITARY HEALTH SYSTEM. GR126855 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541715 Parent award performance state: OH Parent award description: FY20 NEW START JW200164 View parent award on USAspending | — | $422,701 | Apr 28, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Veterans AffairsGov-sourced
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
- Department of Homeland SecurityGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.